Company snapshot
Market Cap
$56B
Large-cap2016 — today
10-Year Price
+218%
2016 — today
52-Week Range
$147.47$248.61
Current $234.57· 86%
Featured in rankings
S&P500Dividend AristocratsMost Undervalued Healthcare StocksBest Healthcare Dividend StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth Stocks
Rankings recomputed after each US market close — see where CAH stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| TAKTakeda Pharmaceutical Company Limited | 49.6 | 3.4% |
| CORCencora, Inc. | 23.9 | 0.8% |
| HUMHumana Inc. | 38.8 | 0.9% |
| BDXBecton, Dickinson and Company | 53.6 | 2.2% |
| ARGXargenx SE | 28.0 | — |
| EWEdwards Lifesciences Corporation | 48.5 | — |
| BSXBoston Scientific Corporation | 17.5 | — |
| NTRANatera, Inc. | -241.9 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
32.4
Historically pricey
Historically pricey — last 10 years
Sector median 24.4above sector
P/B ratio
-20.4
N/A
Not meaningful — company is unprofitable
Sector median 2.5below sector
EV / EBITDA
17.4
Historically pricey
Historically pricey — last 10 years
Sector median 15.2above sector
Dividend Yield
0.9%
Near historic low
Near historic low — last 10 years
Sector median 1.9%below sector
PEG ratio
1.1
Historically cheap
Historically cheap relative to the last 10 years
Sector median 1.5below sector
FCF Yield
8.1%
Below average
Below the 10-year average
Sector median -9.6%above sector